-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Matinas BioPharma Holdings, Inc. annual/quarterly Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from 2018 to 2023.
- Matinas BioPharma Holdings, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending March 31, 2023 was $1.1M.
- Matinas BioPharma Holdings, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $1.1M, a 65.6% decline from 2022.
- Matinas BioPharma Holdings, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $3.19M, a 9561% increase from 2021.
- Matinas BioPharma Holdings, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2021 was $33K, a 79.2% decline from 2020.
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Annual Growth (%)